Profiel
Maud Brandely worked as the Director of Oncology Clinical Development at Pierre Fabre SA and as the Director of Taxotere Clinical Development at Rhone-Poulenc SA. From 2016 to 2024, Dr. Brandely served as the Chief Medical Officer & VP of Medical Affairs at Transgene SA. Dr. Brandely obtained a graduate and doctorate degree from Université Pierre et Marie Curie.
Eerdere bekende functies van Maud Brandely
| Bedrijven | Functie | Einde |
|---|---|---|
| TRANSGENE | Hoofd Techniek/Wetenschap/O&O | 10-09-2024 |
Pierre Fabre SA
Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals | Corporate Officer/Principal | 01-02-2016 |
Rhone-Poulenc SA
Rhone-Poulenc SA Chemicals: SpecialtyProcess Industries Manufactures and supplies chemicals | Corporate Officer/Principal | - |
Opleiding van Maud Brandely
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Transgene SA
Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Pierre Fabre SA
Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals | Health Technology |
Rhone-Poulenc SA
Rhone-Poulenc SA Chemicals: SpecialtyProcess Industries Manufactures and supplies chemicals | Process Industries |
Université Pierre et Marie Curie
Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















